Recruiting NA Deafness

New treatment option for Deafness

Official title Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

ClinicalTrials.gov ID: NCT05810220

What this study is testing

What it's testing
This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 2 to 90

You may be able to join if

  • Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.
  • No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to...
  • Patients' implant device must have useable electrodes that do not result in uncomfortable or unpleasant non-auditory sensation.

You likely can't join if

  • Diagnosed cognitive or communicative disorders (other than hearing impairment)
  • Severe neurological disorders
  • No useable electrodes in their implants

The study team makes the final eligibility decision.

Where it's taking place

  • New York, New York, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 2 years to 90 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.